| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.7B | $3.8B | $3.8B | $3.6B | $0.9B |
| Cost of Revenue | $2.8B | $2.7B | $2.8B | $3.0B | $2.7B | $2.3B |
| Gross Profit | $0.9B | $1.0B | $0.9B | $0.8B | $0.8B | $0.3B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.3B | $0.4B | $0.3B | $0.3B | $0.3B | $0.1B |
| EPS (Basic) | $1.43 | $1.68 | $1.42 | $1.23 | $1.54 | $0.53 |
| EPS (Diluted) | $1.43 | $1.67 | $1.42 | $1.23 | $1.54 | $0.53 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $4.9B | $4.9B | $4.8B | $4.9B | $4.8B | $4.7B |
| Current Assets | $1.1B | $1.1B | $1.0B | $1.2B | $1.1B | $1.1B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.0B | $0.2B | $0.3B |
| Total Liabilities | $2.7B | $2.7B | $2.8B | $3.1B | $3.1B | $3.1B |
| Current Liabilities | $0.6B | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B |
| Stockholders' Equity | $2.3B | $2.1B | $2.0B | $1.9B | $1.8B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.6B | $0.2B | $0.3B | $0.3B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.3B | $-0.3B | $-0.5B | $-0.2B | $-0.3B | $0.0B |